Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 246 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-03-13 | 2019-07-12 | 78484 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-08-21 | 2019-10-15 | 92022 |
| APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2019-10-09 | 2019-11-04 | 95871 |
| APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108927 |
| APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2020-10-07 | 2021-01-26 | 125806 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2020-11-19 | 2020-11-27 | 128594 |
| APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131148 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-02-26 | 2021-08-23 | 134811 |
| APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-18 | 2021-07-26 | 141247 |
| APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-12 | 2023-01-13 | 166604 |
| APO-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2017-03-17 | 2017-07-17 | 3160 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-01-31 | 2018-05-05 | 37732 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-10-25 | 2018-11-22 | 65599 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-03 | 2019-05-17 | 71136 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-05 | 2020-04-04 | 77852 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-24 | 2020-08-17 | 118766 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-05-07 | 2021-09-20 | 138960 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-11-09 | 2022-01-06 | 148999 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-28 | 2022-03-24 | 153783 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-29 | 2022-12-17 | 159703 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
| ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 |